NCT05994092View on ClinicalTrials.gov

Influence of Voluntary Isocapnic Hyperpnea on Blood Lactate Level and Rate of Perceived Exertion

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 10, 2023

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2023

Conditions
Blood Lactate Decrease
Interventions
BEHAVIORAL

Voluntary Isocapnic Hyperpnea

The protocol of 3' of breathing with 20 breaths·min-1 frequency. The Isocapnic BreathWayBetter devices (Isocapnic Technologies Inc, Kelowna, Canada) with 6-liter bags were used. The protocol was performed in a seating position.

Trial Locations (1)

01-982

Institute of Sport - National Research Institute, Warsaw

All Listed Sponsors
lead

Institute of Sport - National Research Institute, Poland

OTHER

NCT05994092 - Influence of Voluntary Isocapnic Hyperpnea on Blood Lactate Level and Rate of Perceived Exertion | Biotech Hunter | Biotech Hunter